DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

The Latest 1-10

Post-grant oppositions for Pharma patents (Part 2): What advantages do they hold over district court litigation?

Category: DRG Blog

As of this writing, patents protecting a number of drugs, including several blockbusters (e.g., Humira, Rituxan, Avastin, Tecfidera, Copaxone, etc.),...

Niyati Khetarpal, Senior Research Associate  / 3 days ago
No comments

What is the ‘high-fat’ content on the ACC.17 menu?

Category: DRG Blog

High-fat diets are all the rage these days, and ACC.17 has some serious high-fat content on the menu for dyslipidemia devotees. Some of the fare...

Tim Blackstock, Principal Analyst  / 2 weeks ago
One comment
1-10 of 1419